MNVAX | VITSX | MNVAX / VITSX | |
Total Expense Ratio | 1.16 | 0.03 | 3,867% |
Annual Report Gross Expense Ratio | 1.16 | 0.03 | 3,867% |
Fund Existence | 12 years | 28 years | - |
Gain YTD | 0.896 | 10.352 | 9% |
Front Load | 6% | N/A | - |
Min. Initial Investment | 1000 | 5000000 | 0% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 383M | 1.95T | 0% |
Annual Yield % from dividends | 0.32 | 1.17 | 28% |
Returns for 1 year | -0.53 | 18.04 | -3% |
Returns for 3 years | 23.62 | 63.66 | 37% |
Returns for 5 years | 21.42 | 84.98 | 25% |
Returns for 10 years | 45.46 | 224.85 | 20% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
IBRN | 25.90 | 0.47 | +1.86% |
iShares Neuroscience and Healthcare ETF | |||
FCOR | 47.99 | 0.20 | +0.42% |
Fidelity Corporate Bond ETF | |||
FTGS | 35.62 | 0.02 | +0.05% |
First Trust Growth Strength ETF | |||
FNGD | 5.54 | -0.12 | -2.12% |
MicroSectors™ FANG+™ -3X Invrs Lvrgd ETN | |||
NVOX | 3.56 | -0.13 | -3.52% |
Defiance Daily Target 2X Long NVO ETF |